These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 14965771)

  • 1. A favorable solubility partner for the recombinant expression of streptavidin.
    Sørensen HP; Sperling-Petersen HU; Mortensen KK
    Protein Expr Purif; 2003 Dec; 32(2):252-9. PubMed ID: 14965771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High level soluble production of functional ribonuclease inhibitor in Escherichia coli by fusing it to soluble partners.
    Guo W; Cao L; Jia Z; Wu G; Li T; Lu F; Lu Z
    Protein Expr Purif; 2011 Jun; 77(2):185-92. PubMed ID: 21292012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners.
    Nallamsetty S; Waugh DS
    Protein Expr Purif; 2006 Jan; 45(1):175-82. PubMed ID: 16168669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New fusion protein systems designed to give soluble expression in Escherichia coli.
    Davis GD; Elisee C; Newham DM; Harrison RG
    Biotechnol Bioeng; 1999 Nov; 65(4):382-8. PubMed ID: 10506413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble expression of archaeal proteins in Escherichia coli by using fusion-partners.
    Kim S; Lee SB
    Protein Expr Purif; 2008 Nov; 62(1):116-9. PubMed ID: 18657619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble expression of a functionally active Plasmodium falciparum falcipain-2 fused to maltose-binding protein in Escherichia coli.
    Goh LL; Loke P; Singh M; Sim TS
    Protein Expr Purif; 2003 Dec; 32(2):194-201. PubMed ID: 14965764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced solubility of heterologous proteins by fusion expression using stress-induced Escherichia coli protein, Tsf.
    Han KY; Song JA; Ahn KY; Park JS; Seo HS; Lee J
    FEMS Microbiol Lett; 2007 Sep; 274(1):132-8. PubMed ID: 17608803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N-domain of Escherichia coli phosphoglycerate kinase is a novel fusion partner to express aggregation-prone heterologous proteins.
    Song JA; Lee DS; Park JS; Han KY; Lee J
    Biotechnol Bioeng; 2012 Feb; 109(2):325-35. PubMed ID: 21882174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli malate dehydrogenase, a novel solubility enhancer for heterologous proteins synthesized in Escherichia coli.
    Park JS; Han KY; Song JA; Ahn KY; Seo HS; Lee J
    Biotechnol Lett; 2007 Oct; 29(10):1513-8. PubMed ID: 17549433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated solubility-enhancing fusion partners MBP and NusA utilize a similar mode of action.
    Raran-Kurussi S; Waugh DS
    Biotechnol Bioeng; 2014 Dec; 111(12):2407-11. PubMed ID: 24942647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving solubility of Shewanella oneidensis MR-1 and Clostridium thermocellum JW-20 proteins expressed into Esherichia coli.
    Kataeva I; Chang J; Xu H; Luan CH; Zhou J; Uversky VN; Lin D; Horanyi P; Liu ZJ; Ljungdahl LG; Rose J; Luo M; Wang BC
    J Proteome Res; 2005; 4(6):1942-51. PubMed ID: 16335938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of C-terminal Escherichia coli translation initiation factor IF2 by small-angle X-ray scattering.
    Rasmussen LC; Oliveira CL; Jensen JM; Pedersen JS; Sperling-Petersen HU; Mortensen KK
    Biochemistry; 2008 May; 47(20):5590-8. PubMed ID: 18442259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The solubility and stability of recombinant proteins are increased by their fusion to NusA.
    De Marco V; Stier G; Blandin S; de Marco A
    Biochem Biophys Res Commun; 2004 Sep; 322(3):766-71. PubMed ID: 15336530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ribosomal stalk binds to translation factors IF2, EF-Tu, EF-G and RF3 via a conserved region of the L12 C-terminal domain.
    Helgstrand M; Mandava CS; Mulder FA; Liljas A; Sanyal S; Akke M
    J Mol Biol; 2007 Jan; 365(2):468-79. PubMed ID: 17070545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced soluble expression of recombinant Flavobacterium heparinum heparinase I in Escherichia coli by fusing it with various soluble partners.
    Huang J; Cao L; Guo W; Yuan R; Jia Z; Huang K
    Protein Expr Purif; 2012 Jun; 83(2):169-76. PubMed ID: 22503820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autodisplay of streptavidin.
    Park M; Jose J; Thömmes S; Kim JI; Kang MJ; Pyun JC
    Enzyme Microb Technol; 2011 Apr; 48(4-5):307-11. PubMed ID: 22112942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cu/Zn incorporation during purification of soluble human EC-SOD from E. coli stabilizes proper disulfide bond formation.
    Bae JY; Koo BK; Ryu HB; Song JA; Nguyen MT; Vu TT; Son YJ; Lee HK; Choe H
    Appl Biochem Biotechnol; 2013 Mar; 169(5):1633-47. PubMed ID: 23329142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and purification of soluble monomeric streptavidin in Escherichia coli.
    Demonte D; Dundas CM; Park S
    Appl Microbiol Biotechnol; 2014; 98(14):6285-95. PubMed ID: 24691867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size of the ligand complex between the N-terminal domain of the gene III coat protein and the non-infectious phage strongly influences the usefulness of in vitro selective infective phage technology.
    Cèbe R; Geiser M
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):841-9. PubMed ID: 11104694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein engineering of streptavidin for in vivo assembly of streptavidin beads.
    Peters V; Rehm BH
    J Biotechnol; 2008 Apr; 134(3-4):266-74. PubMed ID: 18367283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.